News & Updates

Once-weekly treatment with semaglutide, when administered with lifestyle intervention, leads to greater reduction in body mass index among adolescents with obesity as compared with lifestyle intervention alone, as shown in the STEP TEENS study.

Initiating a once-weekly treatment regimen of semaglutide helps control glycated haemoglobin (HbA1c) levels and body weight in patients with type 2 diabetes, without introducing new safety concerns, a Japan study has found.

The risk of depression is higher in individuals with endocrine-metabolic disorders, which can be explained by genetic and environmental influences, reveals a study.

Transmetatarsal amputation (TMA) appears to be an effective approach in diabetes management and can help avoid lower-extremity amputations (LEA), a recent study has found. However, patient-related factors such as insulin dependence and serum albumin affect the procedure’s efficacy.

Among patients with type 2 diabetes, clinical inertia appears to worsen long-term glycaemic control, reports a recent study.

Patients with severe obesity and nonalcoholic fatty liver disease (NAFLD) appear to benefit from bariatric surgery, which significantly reduces the risk of cardiovascular disease (CVD), a study has found.

Women appear to experience premature menopause in the presence of diabetes, according to a study.

Treatment with dulaglutide is both effective and safe in Asians with type 2 diabetes mellitus (T2DM), a recent meta-analysis has found.